ADVATE Side Effects

7012075-4 | Hypoaesthesia, Monoplegia
on Sep 16, 2010 Male patient from UNITED STATES , 47 years of age, weighting 143.3 lb, was diagnosed with haemophilia, cardiac disorder and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, monoplegia. Advate dosage: . During the same period patient was treated with DIGITALIS TAB (View Digitalis Tab Review and Digitalis Tab Label ).

6967611-0 | Cerebral Haemorrhage
Patient was taking Advate (View Usage). Patient had the following side effects: cerebral haemorrhage on Aug 27, 2010 from JAPAN Additional patient health information: Male patient , 63 years of age, weighting 160.9 lb, was diagnosed with factor viii deficiency, hypertension, gastritis, convulsion, prophylaxis and. Advate dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), GASTER D (View Gaster D Review and Gaster D Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PRIMIDONE (View Primidone Review and Primidone Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ), JUVELA (View Juvela Review and Juvela Label ).

6966744-2 | Meningitis Pneumococcal
Adverse event was reported on Aug 26, 2010 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: JAPAN , weighting 19.84 lb, After Advate was administered, patient had the following side effects: meningitis pneumococcal. Patient was hospitalized.

6944897-X | Hepatic Failure
on Aug 17, 2010 Male patient from JAPAN , 50 years of age, weighting 176.4 lb, was diagnosed with factor viii deficiency, hepatic cirrhosis and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure. Advate dosage: . During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ).


6920902-1 | Brain Stem Haemorrhage
on Aug 03, 2010 Male patient from JAPAN , 45 years of age, weighting 160.9 lb, was diagnosed with factor viii deficiency, haemorrhage prophylaxis, hiv infection (What is hiv infection?) and was treated with Advate (View Usage). Patient had the following side effects: brain stem haemorrhage. Advate dosage: . During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), ABACAVIR SULFATE W/LAMIVUDINE/ZIDOVUDINE (View Abacavir Sulfate W/lamivudine/zidovudine Review and Abacavir Sulfate W/lamivudine/zidovudine Label ), STOCRIN (View Stocrin Review and Stocrin Label ). Patient was hospitalized.

6905418-0 | Myoclonus
Patient was taking Advate (View Usage). After Advate was administered, patient had the following side effects: myoclonus on Jul 28, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , child 9 years of age, weighting 79.37 lb, was diagnosed with factor viii deficiency and. Advate dosage: . During the same period patient was treated with KEFLOR (View Keflor Review and Keflor Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), VOREN (View Voren Review and Voren Label ), OXETHAZINE (View Oxethazine Review and Oxethazine Label ), DANSE (View Danse Review and Danse Label ), ASVERIN (View Asverin Review and Asverin Label ), M E (View M-e Review and M-e Label ). Patient was hospitalized.

6900048-9 | Factor Viii Inhibition, Subdural Haematoma
Adverse event was reported on Jul 23, 2010 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with knee operation, factor viii deficiency, subdural haematoma and. Location: JAPAN , 80 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: factor viii inhibition, subdural haematoma. Patient was hospitalized.

6894300-3 | Factor Viii Inhibition, Muscle Haemorrhage
on Jul 28, 2010 Male patient from JAPAN , 55 years of age, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). Patient had the following side effects: factor viii inhibition, muscle haemorrhage. Advate dosage: . During the same period patient was treated with NOVOSEVEN (View Novoseven Review and Novoseven Label ), FEIBA (View Feiba Review and Feiba Label ). Patient was hospitalized.

6856483-0 | Bacteraemia, Muscle Haemorrhage, Otitis Media
on Jul 16, 2010 Male patient from UNITED STATES , child 1 years of age, weighting 23.37 lb, was diagnosed with factor viii deficiency, prophylaxis and was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: bacteraemia, muscle haemorrhage, otitis media. Advate dosage: 623 International Units X 1 Iv Bolus, Advate Infusions.

6814231-4 | Myoclonus
Patient was taking Advate (View Usage). Patient experienced the following unwanted or unexpected effects: myoclonus on Jun 21, 2010 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , child 9 years of age, weighting 79.37 lb, was diagnosed with factor viii deficiency and. Advate dosage: . During the same period patient was treated with KEFLOR (View Keflor Review and Keflor Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), VOREN (View Voren Review and Voren Label ), OXETHAZINE (View Oxethazine Review and Oxethazine Label ), DANSE (View Danse Review and Danse Label ), ASVERIN (View Asverin Review and Asverin Label ), M E (View M-e Review and M-e Label ). Patient was hospitalized.

6774653-7 | Myoclonus
Adverse event was reported on Jun 09, 2010 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: TAIWAN, PROVINCE OF CHINA , child 9 years of age, weighting 79.37 lb, Patient had the following side effects: myoclonus. During the same period patient was treated with KEFLOR (View Keflor Review and Keflor Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), VOREN (View Voren Review and Voren Label ), OXETHAZINE (View Oxethazine Review and Oxethazine Label ), DANSE (View Danse Review and Danse Label ), ASVERIN (View Asverin Review and Asverin Label ), M E (View M-e Review and M-e Label ). Patient was hospitalized.

6774595-7 | Moyamoya Disease
on Jun 08, 2010 Male patient from JAPAN , weighting 187.4 lb, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: moyamoya disease. Advate dosage: .

6760509-2 | Factor Viii Inhibition
on Jun 09, 2009 Male patient from UNITED STATES , child 1 years of age, weighting 26.90 lb, was diagnosed with haemophilia, haemorrhage, haemorrhage intracranial and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition. Advate dosage: 25 Iu/kg; As Needed; Iv : 25 Iu/kg; As Needed; Iv : ;as Needed.

6760506-7 | Factor Viii Inhibition
Patient was taking Advate (View Usage). Patient had the following side effects: factor viii inhibition on Mar 24, 2009 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, was diagnosed with haemophilia and. Advate dosage: .

6760504-3 | Hypersensitivity
Adverse event was reported on Mar 19, 2009 by a Male patient taking Advate (View Usage) (Dosage: ) . Location: UNITED STATES , 20 years of age, After Advate was administered, patient had the following side effects: hypersensitivity.

6760499-2 | Factor Viii Inhibition
on Mar 16, 2009 Male patient from UNITED STATES , child 4 years of age, was diagnosed with haemophilia and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: factor viii inhibition. Advate dosage: .

6760498-0 | Dyspnoea, Rash, Urticaria
on May 04, 2009 Male patient from UNITED STATES , child 7 years of age, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). Patient had the following side effects: dyspnoea, rash (What is rash?), urticaria. Advate dosage: ;every 2 Dy;iv : ;every Day;iv. During the same period patient was treated with ANTIHEMOPHILIC FACTOR (HUMAN) (View Antihemophilic Factor (human) Review and Antihemophilic Factor (human) Label ).

6760491-8 | Factor Viii Inhibition
Patient was taking Advate (View Usage). After Advate was administered, patient had the following side effects: factor viii inhibition on Jul 29, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 25.35 lb, was diagnosed with factor viii deficiency, haemorrhage and. Advate dosage: 518 Iu ; Prn ; Iv. During the same period patient was treated with FACTOR VIIA (View Factor Viia Review and Factor Viia Label ).

6760489-X | Factor Viii Inhibition, Haemoglobin Decreased
Adverse event was reported on Aug 14, 2008 by a Male patient taking Advate (View Usage) (Dosage: 500 Iu ; Every Week ; Iv) was diagnosed with haemophilia, prophylaxis and. Location: UNITED STATES , weighting 27.12 lb, Patient experienced the following unwanted or unexpected effects: factor viii inhibition, haemoglobin decreased. Patient was hospitalized and became disabled.

6733302-4 | Hypoaesthesia, Moyamoya Disease
on May 11, 2010 Male patient from JAPAN , weighting 187.4 lb, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). Patient had the following side effects: hypoaesthesia, moyamoya disease. Advate dosage: .

6709324-6 | Factor Viii Inhibition
on Apr 22, 2010 Male patient from UNITED STATES , 15 years of age, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: factor viii inhibition. Advate dosage: . During the same period patient was treated with FEIBA VH IMMUNO (View Feiba Vh Immuno Review and Feiba Vh Immuno Label ), NOVOSEVEN (View Novoseven Review and Novoseven Label ).

6706639-2 | Coagulation Factor Viii Level Decreased
Patient was taking Advate (View Usage). Patient experienced the following unwanted or unexpected effects: coagulation factor viii level decreased on Apr 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 24.25 lb, was diagnosed with surgery (What is surgery?), haemorrhage prophylaxis, factor viii deficiency and. Advate dosage: .

6690540-7 | Coagulation Factor Viii Level Decreased
Adverse event was reported on Apr 14, 2010 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with surgery (What is surgery?), haemorrhage prophylaxis, factor viii deficiency and. Location: UNITED STATES , weighting 24.25 lb, Patient had the following side effects: coagulation factor viii level decreased.

6686653-6 | Incorrect Dose Administered
on Apr 16, 2010 Male patient from UNITED STATES , weighting 28.66 lb, was diagnosed with haemophilia, prophylaxis and was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: incorrect dose administered. Advate dosage: 756 International Units Every Friday Iv Bolus.

6682964-9 | Meningitis Pneumococcal
on Apr 01, 2010 Male patient from JAPAN , weighting 19.84 lb, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: meningitis pneumococcal. Advate dosage: .

6663957-4 | Arthralgia, Joint Range Of Motion Decreased, Joint Swelling
Patient was taking Advate (View Usage). Patient had the following side effects: arthralgia, joint range of motion decreased, joint swelling on Mar 24, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , child 8 years of age, weighting 97.00 lb, was diagnosed with haemophilic arthropathy and. Advate dosage: . Patient was hospitalized.

6657335-1 | Central Venous Catheterisation, Factor Viii Inhibition, Muscle Haemorrhage
Adverse event was reported on Mar 24, 2010 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: BELGIUM , weighting 26.46 lb, After Advate was administered, patient had the following side effects: central venous catheterisation, factor viii inhibition, muscle haemorrhage. Patient was hospitalized.

6642158-X | Arthralgia, Joint Range Of Motion Decreased, Joint Swelling
on Mar 08, 2010 Male patient from KOREA, REPUBLIC OF , child 8 years of age, weighting 97.00 lb, was diagnosed with haemophilic arthropathy and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, joint range of motion decreased, joint swelling. Advate dosage: . During the same period patient was treated with RECOMBINATE (View Recombinate Review and Recombinate Label ), HUMAN FACTOR VIII (View Human Factor Viii Review and Human Factor Viii Label ). Patient was hospitalized.

6628703-9 | Factor Viii Inhibition
on Mar 03, 2010 Male patient from UNITED KINGDOM , child 4 years of age, was diagnosed with haemophilia, factor viii inhibition and was treated with Advate (View Usage). Patient had the following side effects: factor viii inhibition. Advate dosage: .

6587861-5 | Central Venous Catheterisation, Factor Viii Inhibition, Muscle Haemorrhage
Patient was taking Advate (View Usage). After Advate was administered, patient had the following side effects: central venous catheterisation, factor viii inhibition, muscle haemorrhage on Feb 10, 2010 from BELGIUM Additional patient health information: Male patient , weighting 26.46 lb, was diagnosed with factor viii deficiency and. Advate dosage: . Patient was hospitalized.

6582590-6 | Central Venous Catheterisation, Factor Viii Inhibition, Muscle Haemorrhage
Adverse event was reported on Feb 10, 2010 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: BELGIUM , weighting 26.46 lb, Patient experienced the following unwanted or unexpected effects: central venous catheterisation, factor viii inhibition, muscle haemorrhage. Patient was hospitalized.

6576317-1 | Renal Failure
on Feb 02, 2010 Male patient from JAPAN , 81 years of age, weighting 132.3 lb, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). Patient had the following side effects: renal failure. Advate dosage: . During the same period patient was treated with HEMOFIL M (View Hemofil M Review and Hemofil M Label ), RECOMBINATE (View Recombinate Review and Recombinate Label ).

6540916-3 | Factor Viii Inhibition, Renal Haematoma
on Jul 28, 2009 Male patient from UNITED STATES , weighting 17.64 lb, was diagnosed with factor viii deficiency and was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: factor viii inhibition, renal haematoma. Advate dosage: . Patient was hospitalized.

6520294-6 | Abdominal Pain, Hypotonia, Pallor, Petechiae
Patient was taking Advate (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), hypotonia, pallor, petechiae on Dec 23, 2009 from UNITED KINGDOM Additional patient health information: Male patient , child 4 years of age, weighting 37.48 lb, was diagnosed with factor viii deficiency and. Advate dosage: . During the same period patient was treated with SYTRON (View Sytron Review and Sytron Label ).

6509743-7 | Renal Failure
Adverse event was reported on Dec 14, 2009 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with factor viii deficiency and. Location: JAPAN , 81 years of age, weighting 132.3 lb, Patient had the following side effects: renal failure. During the same period patient was treated with HEMOFIL M (View Hemofil M Review and Hemofil M Label ), RECOMBINATE (View Recombinate Review and Recombinate Label ).

6442559-9 | Chest Pain, Dyspnoea, Hangover, Headache, Hyperhidrosis
on Nov 11, 2009 Male patient from UNITED KINGDOM , 57 years of age, weighting 143.3 lb, was diagnosed with haemophilia and was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, hangover, headache (What is headache?), hyperhidrosis. Advate dosage: . During the same period patient was treated with ACETAMINOPHEN WITH PROPOXYPHENE HCL TAB (View Acetaminophen With Propoxyphene Hcl Tab Review and Acetaminophen With Propoxyphene Hcl Tab Label ).

6437129-2 | Somnambulism
on Nov 04, 2009 Male patient from POLAND , 14 years of age, weighting 127.9 lb, was diagnosed with factor viii deficiency, somnambulism, pharyngitis and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: somnambulism. Advate dosage: . During the same period patient was treated with NOOTROPIL (View Nootropil Review and Nootropil Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), OMEGA 3 MARINE TRIGLYCERIDES (View Omega-3 Marine Triglycerides Review and Omega-3 Marine Triglycerides Label ), ATARAX (View Atarax Review and Atarax Label ), SEBIDIN (View Sebidin Review and Sebidin Label ). Patient was hospitalized.

6433835-4 | Catheter Placement, Factor Viii Inhibition
Patient was taking Advate (View Usage). Patient had the following side effects: catheter placement, factor viii inhibition on Nov 04, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 24.25 lb, was diagnosed with factor viii deficiency and. Advate dosage: . Patient was hospitalized and became disabled.

6424388-5 | Investigation
Adverse event was reported on Oct 23, 2009 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with haemophilia and. Location: POLAND , 14 years of age, weighting 127.9 lb, After Advate was administered, patient had the following side effects: investigation. Patient was hospitalized.

6422335-3 | Haematoma
on Sep 30, 2009 Male patient from UNITED STATES , child 7 years of age, weighting 39.68 lb, was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma. Advate dosage: . Patient was hospitalized.

6419555-0 | Bacteraemia, Enterobacter Infection
on Oct 22, 2009 Male patient from UNITED STATES , child 7 years of age, weighting 46.30 lb, was treated with Advate (View Usage). Patient had the following side effects: bacteraemia, enterobacter infection. Advate dosage: . Patient was hospitalized.

6407162-5 | Catheter Placement, Factor Viii Inhibition
Patient was taking Advate (View Usage). After Advate was administered, patient had the following side effects: catheter placement, factor viii inhibition on Oct 09, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 24.25 lb, was diagnosed with factor viii deficiency and. Advate dosage: . Patient was hospitalized and became disabled.

6401434-6 | Haemorrhage
Adverse event was reported on Oct 06, 2009 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with haemophilia and. Location: CANADA , 67 years of age, Patient experienced the following unwanted or unexpected effects: haemorrhage.

6397080-3 | Bacteraemia, Enterobacter Infection
on Sep 30, 2009 Male patient from UNITED STATES , child 7 years of age, weighting 46.30 lb, was treated with Advate (View Usage). Patient had the following side effects: bacteraemia, enterobacter infection. Advate dosage: . Patient was hospitalized.

6394619-9 | Bacteraemia, Bacterial Infection
on Sep 30, 2009 Male patient from UNITED STATES , child 7 years of age, weighting 37.48 lb, was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: bacteraemia, bacterial infection (What is bacterial infection?). Advate dosage: . Patient was hospitalized.

6394498-X | Bacteraemia, Enterobacter Infection
Patient was taking Advate (View Usage). Patient experienced the following unwanted or unexpected effects: bacteraemia, enterobacter infection on Sep 30, 2009 from UNITED STATES Additional patient health information: Male patient , child 7 years of age, weighting 46.30 lb, . Advate dosage: . Patient was hospitalized.

6393192-9 | Central Venous Catheterisation, Factor Viii Inhibition
Adverse event was reported on Sep 23, 2009 by a Male patient taking Advate (View Usage) (Dosage: ) was diagnosed with haemophilia and. Location: AUSTRALIA , weighting 24.25 lb, Patient had the following side effects: central venous catheterisation, factor viii inhibition. Patient was hospitalized.

6393160-7 | Haematoma
on Sep 30, 2009 Male patient from UNITED STATES , child 7 years of age, weighting 39.68 lb, was treated with Advate (View Usage). After Advate was administered, patient had the following side effects: haematoma. Advate dosage: . Patient was hospitalized.

6391774-1 | Muscle Haemorrhage
on Jun 11, 2009 Male patient from AUSTRALIA , weighting 22.05 lb, was diagnosed with haemophilia and was treated with Advate (View Usage). Patient experienced the following unwanted or unexpected effects: muscle haemorrhage. Advate dosage: . Patient was hospitalized.

6389421-8 | Haemorrhage
Patient was taking Advate (View Usage). Patient had the following side effects: haemorrhage on Sep 28, 2009 from CANADA Additional patient health information: Male patient , 67 years of age, was diagnosed with haemophilia and. Advate dosage: .